The Helicobacter Pylori (H. pylori) non-invasive testing market is expected to grow from US$ 596.82 million in 2021 to US$ 800.04 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2022 to 2028.
The rising prevalence of H. pylori infection and technological advancements are driving the overall market growth. Further, strategies implemented by major players provide lucrative opportunities in the global market.
Helicobacter Pylori (HP) is a major factor responsible for peptic ulcer disease and gastritis. As per the Public Library of Science (PLOS) report, approximately one-third of all adults in Northern Europe and North America are infected with HP, with a very high prevalence in Africa, South & Central America, Asia, and Southern & Eastern Europe accounting for 50%. Also, HP infection is high among adults with some geographical variations. For example, the National Institute of Health (NIH) report states that the infection of H. pylori among adolescents is 30-50%, and among adults, it reaches 90% in developing countries.
The Clinical and Experimental Pediatrics (CEP) report states that the prevalence of H. pylori infection has decreased. Although the H. pylori infection rate has decreased in South Korea and developed countries, 33% of asymptomatic or healthy children are still infected serologically worldwide, as per the same report. For example, developed countries such as Japan, Germany, the Netherlands, and the US reported low seroprevalence, accounting for 7.7%, 11.8%, 9.8%, and 5.7%, respectively, in 2020. However, high infection rates of 27.2%, 65.9%, 25.8%, and 40.4% were reported in Chile, Venezuela, Iran, and Nigeria, respectively, in the same year. Therefore, the rising prevalence of H. pylori infection accelerates the demand for non-invasive testing, ultimately fueling the growth of the Helicobacter Pylori (H. pylori) non-invasive testing market during the forecast period.
Helicobacter Pylori (H. pylori) Non-Invasive Testing Market -
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Helicobacter Pylori (H. pylori) Non-Invasive Testing Market: Strategic Insights
Market Size Value in US$ 596.82 Million in 2021 Market Size Value by US$ 800.04 Million by 2028 Growth rate CAGR of 4.4% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Helicobacter Pylori (H. pylori) Non-Invasive Testing Market: Strategic Insights
| Market Size Value in | US$ 596.82 Million in 2021 |
| Market Size Value by | US$ 800.04 Million by 2028 |
| Growth rate | CAGR of 4.4% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Helicobacter Pylori (H. pylori) is a bacterial infection that is majorly detected in patients suffering from gastric and duodenal ulcers. For instance, the Centers for Disease Control and Infection (CDC) report states that the prevalence of H. pylori infection worldwide is ~50% and ~80-90% in developing countries. Moreover, the prevalence of H. pylori is estimated to be 35-40% in the US. The high prevalence of H. pylori infection positively influences the adoption of non-invasive diagnostic solutions. Technological advancements and innovations in the H. pylori non-invasive testing solutions offer accurate results and greater patient satisfaction among patients suffering from bacterial infection. For example, point-of-care testing (POCT) provides accurate results at an affordable price in a short time. As people with multiple health conditions are usually more vulnerable to infections and seek early detection of H. pylori infection, greater accessibility of POCT and easy availability of numerous invasive and non-invasive devices positively impact the market growth. For instance, in May 2022, Biomerica, Inc. announced a new product launch for the CE mark for its "hp+detect'" diagnostic test responsible for detecting H. pylori bacteria. The new product "hp+detect" product is responsible for detecting H. pylori bacteria, having a prevalence of 35% among the US population and 45% of Europe's five largest countries.
The low diagnosis rate acts as a major restraint for the Helicobacter pylori (H. pylori) non-invasive testing market. Low socio-economic status or a low level of education are associated with an increased prevalence of H. pylori infection. In Australia, the pooled H. pylori prevalence estimated for the general population was 24.6%, but it recorded 76.0% prevalence in the rural Western Australian indigenous community. In the US, the pooled Helicobacter pylori prevalence estimated in the general population was 35.6%; however, in the Alaskan indigenous population, it was 74.8%. Helicobacter pylori (H. pylori) infection is high because it remains asymptomatic for an extended period, so the rate of diagnosis is low for this infection. Most people with H. pylori infection are asymptomatic. This issue can delay the diagnosis of infection, which will limit the demand for non-invasive test kits.
Helicobacter Pylori (H. pylori) Non-Invasive Testing Market - Regional Overview
China holds a considerable share in the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market. China is a developing country in Asia Pacific with a well-established healthcare system and a fast-growing pharmaceutical industry. China is home to various medical, pharmaceutical, and biotechnology product manufacturing companies operating in the global market. These pharmaceuticals and biotechnology companies are involved in the development of various testing kits and devices for H. pylori detection owing to the high prevalence of various H. pylori infections and gastric (stomach) cancer cases, which boosts the growth of the market.
Japan is one of the leading countries with the most advanced medical industry. According to Roswell Park Comprehensive Cancer Center, Japan experiences disproportionately high rates of stomach cancer cases due to high rates of infection with H. pylori and high consumption of smoked and salted foods. Also, gastric cancer is the third deadliest cancer, resulting in the death of ~50,000 people each year in Japan. Furthermore, as per a study (2020) published in Wiley Online Library, H. pylori causes ~98% of gastric cancer in Japan. Although there were many reported reasons for gastric cancer cases, recent studies have shown that the majority of gastric cancer incidence is due to the infection caused by H. pylori. The aforementioned factors are expected to positively impact the Helicobacter pylori (H. pylori) non-invasive testing market growth in Japan during the forecast period.
Helicobacter Pylori (H. pylori) Non-Invasive Testing Market - Test Type Based Insights
Based on test type, the Helicobacter Pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breath. The urea breath segment is estimated to hold the largest market share and the highest CAGR from 2022 to 2028. According to the National Institute of Health (NIH) report, non-invasive H. pylori diagnostic tests are available for point-of-care (POC) intended for primary care by involving IgG serology, C-urea breath test (UBT), and monoclonal stool antigen. Among these, only UBT provides accuracy in confirming current infection or eradication. The Gut and Liver report shows that UBT is non-invasive and accurate with safety among pediatric patients and pregnant women. Thus, the aforementioned factors are likely to boost the market growth for this segment from 2022 to 2028.
Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – 2022 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Companies operating in the Helicobacter Pylori (H. pylori) non-invasive testing market adopt the product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the market.
Helicobacter Pylori (H. pylori) Non-Invasive Testing Market – Segmentation
Based on test type, the Helicobacter Pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breath. The urea breath segment accounted for the largest market share in 2021 and is expected to register the highest CAGR from 2022 to 2028. Based on test method, the market is bifurcated into laboratory based and point-of-care. The laboratory based segment led the market in 2021 and is expected to retain its dominance during the forecast period. Based on end user, the market is segmented into hospitals, clinics, and diagnostic laboratories. The hospitals segment led the market in 2021 and is expected to retain its dominance during the forecast period. Based on geography, the market is primarily segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.
Helicobacter Pylori (H. pylori) Non-Invasive Testing Market - Company Profiles
- DiaSorin S.p.A,
- Meridian Bioscience, Inc.,
- QuidelOrtho Corporation,
- Abbott Laboratories,
- Thermo Fischer Scientific,
- CerTest Biotec,
- Sekisui Diagnostics,
- Coris BioConcept,
- Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.,
- Bio-Rad Laboratories, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Test Type, Test Method, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Helicobacter pylori (H. pylori) is a very motile, spiral, or curved rod-shaped Gram-negative bacteria comprising multiple flagella that live in the gastric mucous-coated lining and the gastric pits of the epithelial tissue of the stomach and/or duodenum. Currently, non-invasive tests are the first methods for diagnosing H. Pylori infection. These tests include serological tests, stool antigen research, and urea breath test.
Increasing prevalence of H. pylori bacterial infection and new product launches and FDA approvals are the most significant factors responsible for the overall market growth.
Based on test type, the urea breath segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
Based on the test method, laboratory-based test method segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
The diagnostic laboratories segment dominated the global Helicobacter pylori (H. pylori) non-invasive testing market and accounted for the largest market share of 59.01% in 2021.
DiaSorin S.p.A., Meridian Bioscience, QuidelOrtho Corporation, Abbott, Thermo Fisher Scientific, Inc., Certest Biotec S.L., Sekisui Diagnostics, CorisBioconcept SPRL, Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., and Bio-Rad Laboratories, Inc. are among the leading companies operating in the H. pylori non-invasive testing market.
Global Helicobacter pylori (H. pylori) non-invasive testing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for H. pylori non-invasive testing market. The growing prevalence of stomach cancer, duodenal ulcers, and gastric ulcers and the development of health care facilities will drive H. pylori non-invasive testing market growth in North America. Further, the rising geriatric population, high prevalence of H. pylori, gastric cancer cases, and expanding partnerships among key players are the key factor responsible for the Asia-Pacific regional growth for H. pylori non-invasive testing market accounting fastest growth of the region during the coming years.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By Test Type
1.3.2 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By Test Method
1.3.3 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By End User
1.3.4 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Experts Opinion
5. Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing prevalence of H. pylori bacterial infection
5.1.2 New Product Launches & FDA Approvals for Noninvasive Tests
5.1.3 Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori
5.1.4 Rise in Investments by Pharmaceutical Companies
5.2 Key Market Restraints
5.2.1 Low Diagnosis Rate
5.3 Key Market Opportunities
5.3.1 Increasing Number of Conferences and Events for Research
5.3.2 Introduction of Artificial Intelligence
5.4 Future Trends
5.4.1 Increasing Use of Home-Based POC Devices
5.4.2 Diagnosis for Resistance
5.5 Impact Analysis
6. Helicobacter pylori (H. pylori) Non-Invasive Testing Market– Global Analysis
6.1 Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue Forecast and Analysis
6.2 Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market – Market Potential Analysis, By Region
6.5 Comparative Company Analysis
6.6 Growth Strategy Analysis
6.7 Performance of Key Players
6.7.1 Abbott
6.7.2 DiaSorin S.p.A.
7. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market Analysis– by Test Type
7.1 Overview
7.2 Global Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Type 2022 & 2028 (%)
7.3 Serology Test
7.3.1 Overview
7.3.2 Global Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Stool Antigen Test
7.4.1 Overview
7.4.2 Global Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Urea Breath Test
7.5.1 Overview
7.5.2 Global Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)
8. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market Analysis– by Test Method
8.1 Overview
8.2 Global Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Method 2022 & 2028 (%)
8.3 Laboratory Based Tests
8.3.1 Overview
8.3.2 Global Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 Point Of Care Tests
8.4.1 Overview
8.4.2 Global Point Of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)
9. Global Helicobacter pylori (H. pylori) Noninvasive Testing Market Analysis– by End User
9.1 Overview
9.2 Global Helicobacter pylori (H. pylori) Non-invasive Testing Market, By End User 2018 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Global Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Clinics
9.4.1 Overview
9.4.2 Global Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Global Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
10. Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market
10.1.1 Overview
10.1.2 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020–2028 (US$ Million)
10.1.4 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020–2028 (US$ Million)
10.1.5 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020–2028 (US$ Million)
10.1.6 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
10.1.6.1 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020–2028 (US$ Million)
10.1.6.1.4 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020–2028 (US$ Million)
10.1.6.1.5 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020–2028 (US$ Million)
10.1.6.2 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020–2028 (US$ Million)
10.1.6.2.4 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020–2028 (US$ Million)
10.1.6.2.5 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020–2028 (US$ Million)
10.1.6.3 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020–2028 (US$ Million)
10.1.6.3.4 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020–2028 (US$ Million)
10.1.6.3.5 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020–2028 (US$ Million)
10.2 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market
10.2.1 Overview
10.2.2 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
10.2.4 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
10.2.6.1 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.4 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.5 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.4 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.5 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.4 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.5 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.4 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.5 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.4 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.5 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts To 2028
10.3.1 Overview
10.3.2 Asia Pacific Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.3 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)
10.3.4 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)
10.3.6 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028, By Country, 2022 & 2028 (%)
10.3.6.1 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.1.3 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)
10.3.6.1.4 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)
10.3.6.1.5 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)
10.3.6.2 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.3 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)
10.3.6.2.4 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)
10.3.6.2.5 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)
10.3.6.3 India Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.3 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)
10.3.6.3.4 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)
10.3.6.3.5 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)
10.3.6.4 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.3 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)
10.3.6.4.4 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)
10.3.6.4.5 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)
10.3.6.5 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.5.3 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)
10.3.6.5.4 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)
10.3.6.5.5 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)
10.4 Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
10.4.4 Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
10.4.5 Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.4.6 Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
10.4.6.1 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.1 Overview
10.4.6.1.2 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
10.4.6.1.4 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
10.4.6.1.5 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.4.6.2 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.1 Overview
10.4.6.2.2 Saudi Arabia Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
10.4.6.2.4 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
10.4.6.2.5 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.4.6.3 South Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 South Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
10.4.6.3.4 South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
10.4.6.3.5 South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.4.6.4 Rest of the Middle East and Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of the Middle East and Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.5 South And Central America Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028
10.5.1 South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.2 South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
10.5.3 South and Central America Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
10.5.4 South and Central America Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)
10.5.5 South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Country (%)
10.5.5.1 Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.1.1 Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.1.2 Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
10.5.5.1.3 Argentina Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
10.5.5.1.4 Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)
10.5.5.2 Brazil Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.2.1 Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.2.2 Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By Test (US$ Mn)
10.5.5.2.3 Brazil Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ MN)
10.5.5.2.4 Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.5.5.3 Rest of South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.3.1 RoSCAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
10.5.5.3.2 RoSCAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
10.5.5.3.3 RoSCAM Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
10.5.5.3.4 RoSCAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)
11. Impact Of COVID-19 Pandemic on H. pylori Non-Invasive Testing Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profile
13.1 DiaSorin S.p.A.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Meridian Bioscience, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QuidelOrtho Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott Laboratories
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CerTest Biotec
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sekisui Diagnostics
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Coris BioConcept
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Bio-Rad Laboratories, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (USD Million)
Table 3. North America Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 4. US Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
Table 6. US Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
Table 21. France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 22. UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
Table 24. UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method– Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).
Table 35. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 37. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).
Table 38. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)
Table 39. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).
Table 41. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 43. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).
Table 44. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)
Table 45. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).
Table 47. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).
Table 50. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).
Table 53. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 55. Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 56. Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
Table 57. Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 58. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 59. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
Table 60. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 61. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 62. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
Table 63. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 64. South Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 65. South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
Table 66. South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 67. Rest of Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 68. Rest of Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
Table 69. Rest of Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 70. South and Central America Helicobacter Pylori : Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 71. South and Central America Helicobacter Pylori :Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (USD Million)
Table 72. South and Central America Helicobacter Pylori: Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 73. Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
Table 74. Argentina Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (USD Million)
Table 75. Argentina Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 76. Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 77. Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (USD Million)
Table 78. Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 79. RoSCAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 80. RoSCAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (USD Million)
Table 81. RoSCAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 82. Recent Inorganic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
Table 83. Recent Organic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
Table 84. Glossary of Terms
LIST OF FIGURES
Figure 1. Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Segmentation
Figure 2. Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, By Region
Figure 3. Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Overview
Figure 4. Urea Breath Segment Held Largest Share of Test Type Segment in Helicobacter Pylori (H. pylori) Non-invasive Testing Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Geography (US$ Million)
Figure 7. Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Leading Country Markets (US$ Million)
Figure 8. Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Helicobacter pylori Non-Invasive Testing Market Impact Analysis of Driver and Restraints
Figure 16. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market– Revenue Forecast and Analysis – 2020 - 2028
Figure 17. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market – By Geography Forecast and Analysis – 2022 - 2028
Figure 18. Market Positioning of Key Players in Helicobacter pylori (H. pylori) Non-Invasive Testing Market
Figure 19. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market – Market Potential Analysis, By Region
Figure 20. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market – Comparative Company Analysis
Figure 21. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market – Growth Strategy Analysis
Figure 22. Global Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Type 2022 & 2028 (%)
Figure 23. Global Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Global Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Global Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Global Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Method 2022 & 2028 (%)
Figure 27. Global Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Global Point Of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Global Helicobacter pylori (H. pylori) Noninvasive Testing Market, by End User 2018 & 2028 (%)
Figure 30. Global Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Global Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Global Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 34. North America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
Figure 36. US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 40. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 41. Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
Figure 42. Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Asia Pacific Helicobacter pylori (H. pylori) Non-Invasive Testing Market Overview, by Country (2022)
Figure 49. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 50. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028, By Country, 2022 & 2028 (%)
Figure 51. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 52. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 53. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 54. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 55. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 56. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 58. Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 59. Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
Figure 60. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 61. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. South Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 63. Rest of the Middle East and Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 64. South and Central America Helicobacter Pylori (H. pylori) Noninvasive Testing Market Revenue Overview, by Country, 2022 (US$ Mn)
Figure 65. South and Central America Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 66. South and Central America Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By Country (%)
Figure 67. Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 68. Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 69. RoSCAM Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 70. Impact of COVID-19 Pandemic on North American Country Markets
Figure 71. Impact of COVID-19 Pandemic on European Country Markets
Figure 72. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
Figure 73. Impact of COVID-19 Pandemic on the Middle East and Africa Country Markets
Figure 74. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 75. Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
The List of Companies - Helicobacter Pylori (H. pylori) Non-invasive Testing Market
- DiaSorin S.p.A.
- Meridian Bioscience Inc.
- QuidelOrtho Corporation
- Abbott Laboratories
- CerTest Biotec
- Thermo Fisher Scientific Inc.
- Sekisui Diagnostics
- Coris BioConcept
- Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
- Bio-Rad Laboratories Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Helicobacter Pylori (H. pylori) Non-Invasive Testing Market
Aug 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Aug 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Aug 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)